Overview of breast cancer

被引：135

作者：

Watkins, Elyse J. ^{[1
,2
,3
]}

机构：

[1] Univ Lynchburg, Sch PA Med, Lynchburg, VA 24501 USA

[2] Florida State Univ, PA Program, Tallahassee, FL 32306 USA

[3] Wake Baptist Hlth, Winston Salem, NC 27157 USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2019年 / 32卷 / 10期

关键词：

nonmetastatic breast cancer; breast imaging; DCIS; triple negative; invasive ductal carcinoma; hormone receptor; STATISTICS; MANAGEMENT;

D O I：

10.1097/01.JAA.0000580524.95733.3d

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Each year, more than 250,000 women in the United States are diagnosed with invasive breast cancer. Although overall mortality for breast cancer patients has declined, it is still the second most common cause of cancer death in women. This article provides an overview of nonmetastatic breast cancer in women, including general features, diagnostic considerations, and treatments for the most common breast cancer subtypes.

引用

页码：13 / 17

页数：5

共 19 条

[1]

Abdelmessieh P., Breast Cancer Histology

[2]

American Cancer Society American Cancer Society, Breast Cancer Facts Figures 2009-2010

[3]

[Anonymous], BREAST CANC RISK ASS

[4]

[Anonymous], ACR BI RANDS ATL

[5]

[Anonymous], NCCN CLIN PRACT GUID

[6] Assessing the Validity of Clinician Advice That Patients Avoid Use of Topical Agents Before Daily Radiotherapy Treatments [J].

Baumann, Brian C. ;

Verginadis, Ioannis I. ;

Zeng, Chuan ;

Bell, Brett ;

Koduri, Sravya ;

Vachani, Carolyn ;

MacArthur, Kelly M. ;

Solberg, Timothy D. ;

Koumenis, Constantinos ;

Metz, James M. .

JAMA ONCOLOGY, 2018, 4 (12) :1742-1748

[7] Breast cancer statistics, 2017, racial disparity in mortality by state [J].

DeSantis, Carol E. ;

Ma, Jiemin ;

Sauer, Ann Goding ;

Newman, Lisa A. ;

Jemal, Ahmedin .

CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (06) :439-448

[8] Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer [J].

Francis, P. A. ;

Pagani, O. ;

Fleming, G. F. ;

Walley, B. A. ;

Colleoni, M. ;

Lang, I. ;

Gomez, H. L. ;

Tondini, C. ;

Ciruelos, E. ;

Burstein, H. J. ;

Bonnefoi, H. R. ;

Bellet, M. ;

Martino, S. ;

Geyer, C. E., Jr. ;

Goetz, M. P. ;

Stearns, V. ;

Pinotti, G. ;

Puglisi, F. ;

Spazzapan, S. ;

Climent, M. A. ;

Pavesi, L. ;

Ruhstaller, T. ;

Davidson, N. E. ;

Coleman, R. ;

Debled, M. ;

Buchholz, S. ;

Ingle, J. N. ;

Winer, E. P. ;

Maibach, R. ;

Rabaglio-Poretti, M. ;

Ruepp, B. ;

Di Leo, A. ;

Coates, A. S. ;

Gelber, R. D. ;

Goldhirsch, A. ;

Regan, M. M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (02) :122-137

[9] Hormone Replacement Therapy and Breast Cancer: Heterogeneous Risks by Race, Weight, and Breast Density [J].

Hou, Ningqi ;

Hong, Susan ;

Wang, Wenli ;

Olopade, Olufunmilayo I. ;

Dignam, James J. ;

Huo, Dezheng .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (18) :1365-1372

[10] US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status [J].

Howlader, Nadia ;

Altekruse, Sean F. ;

Li, Christopher I. ;

Chen, Vivien W. ;

Clarke, Christina A. ;

Ries, Lynn A. G. ;

Cronin, Kathleen A. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (05)

← 1 2 →